67 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Is a Surprise Coming for Lilly (LLY) This Earnings Season? http://www.zacks.com/stock/news/883574/is-a-surprise-coming-for-lilly-lly-this-earnings-season?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-883574 Apr 22, 2020 - Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics http://www.zacks.com/stock/news/883840/the-zacks-analyst-blog-highlights-eli-lilly-dexcom-viewray-chemed-and-sage-therapeutics?cid=CS-ZC-FT-press_releases-883840 Apr 22, 2020 - The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke http://www.zacks.com/stock/news/883863/the-zacks-analyst-blog-highlights-exxon-mobil-oracle-eli-lilly-and-coke?cid=CS-ZC-FT-press_releases-883863 Apr 22, 2020 - The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke
Company News for Apr 24, 2020 http://www.zacks.com/stock/news/887485/company-news-for-apr-24-2020?cid=CS-ZC--corporate_summary-887485 Apr 24, 2020 - Companies In The News Are: LLY, SAVA, FLR, LYTS
Bayer (BAYRY) Q1 Earnings Beat Estimates, Sales Rise Y/Y http://www.zacks.com/stock/news/891610/bayer-bayry-q1-earnings-beat-estimates-sales-rise-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-891610 Apr 27, 2020 - Bayer (BAYRY) beats earnings estimates for the first quarter of 2019.
Top Research Reports for Disney, Novo Nordisk & BHP http://www.zacks.com/research-daily/1055128/top-research-reports-for-disney-novo-nordisk-bhp?cid=CS-ZC-FT-research_daily-1055128 Sep 08, 2020 - Top Research Reports for Disney, Novo Nordisk & BHP
AVEO Acquires Full Global Rights to Ficlatuzumab From Biodesix http://www.zacks.com/stock/news/1055947/aveo-acquires-full-global-rights-to-ficlatuzumab-from-biodesix?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1055947 Sep 09, 2020 - AVEO reclaims complete rights to ficlatuzumab from Biodesix for an undisclosed sum. The candidate is being developed for several cancer indications.
No Econ Data, but Big Biopharma News http://www.zacks.com/stock/news/1057905/no-econ-data-but-big-biopharma-news?cid=CS-ZC-FT-ahead_of_wall_street-1057905 Sep 14, 2020 - Merck, Gilead and Lilly make progress on an otherwise slow news day.
Stock Market News for Sep 15, 2020 http://www.zacks.com/stock/news/1058441/stock-market-news-for-sep-15-2020?cid=CS-ZC--market_news-1058441 Sep 15, 2020 - U.S. stock markets closed higher on Monday reversing some of the losses of the last week.
Roche's Actemra Meets Goal in Phase III Coronavirus Study http://www.zacks.com/stock/news/1060395/roches-actemra-meets-goal-in-phase-iii-coronavirus-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1060395 Sep 18, 2020 - Roche's (RHHBY) phase III study, EMPACTA, evaluating Actemra in patients with COVID-19-associated pneumonia, meets primary endpoint.

Pages: 1234567

<<<Page 3>